Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 4Phase 2/3 2Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 4Recurrence 2Brain Neoplasms 2Astrocytoma 2Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Glioma 1Central Nervous System Neoplasms 1

Interventions

Temozolomide 3vocimagene amiretrorepvec 2Radiotherapy 2Lomustine 2Bevacizumab 2Vorinostat 1Vincristine 1Radiation 1Procarbazine 1Immunoglobulin G 1Flucytosine 1Disulfides 1DNA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Astrocytoma × Lomustine × Clear all
NCT00003375 2024-07-09

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Radiation Therapy Oncology Group

Phase 2/3 Completed
370 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

NCT02414165 2020-02-07

Toca5

Tocagen Inc.

Phase 2/3 Terminated
403 enrolled
CNS

Astrocytoma, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡